Table 2.
Adipokines | Effect on Autophagy | Effect of Autophagy in Cancer |
Experimental Model | Cancer Type | Reference |
---|---|---|---|---|---|
Leptin | Inductor | - | HeLa | Cervical | [143] |
HCT116 | Colorectal | ||||
U2OS | Osteosarcoma | ||||
Leptin and
adipsin |
Inductor | Protects against apoptosis |
U266 | Multiple Myeloma | [144] |
ARP-1 | |||||
Tumor xenograft | |||||
Leptin | Inductor | Maintains proliferation and prevents apoptosis | MCF-7 | Breast | [145] |
HepG2 | Hepatocellular carcinoma | ||||
Tumor Xenograft | |||||
Leptin | Inductor | Promotes tumor growth and proliferation | MCF-7 | Breast | [146] |
Tumor xenograft | |||||
Leptin | Inductor | Promotes proliferation, migration, and morphological change | MCF-7 | Breast | [147] |
Resistin | Inductor | Inhibits doxorubicin-induced apoptosis | MCF-7 | Breast | [149] |
Apelin | Inductor | Promote proliferation and cell migration | A549 | Human lung adenocarcinoma | [90] |
Adiponectin | Inductor | Increased proliferation in glucose-deprivedmedium | DLD-1 | Human Colorectal |
[150] |
HT-29 | Mouse Colorectal | ||||
Adiponectin | Inductor | Adiponectin deficiency fails to induce autophagy, avoiding LDLR turnover and increasing tumor growth. Adiponectin treatment induces autophagy and rescues adiponectin deficiency effects. |
Adiponectin deficient MMTV-PyMT mice and MDA-MB-231 |
Breast | [151] |
Adiponectin | Inductor | Inhibits adiponectin- induced apoptosis |
MCF-7 | Breast | [152] |
HepG2 | Hepatocellular carcinoma | ||||
Adiponectin | Inductor | Cytotoxic, contributes to cancer cell death and decreases tumor growth | MCF-7 | Breast | [153] |
MDA-MB-231 | |||||
Tumor xenograft |